HomeNDC LookupRxCUI directory › RxCUI 1251772

Cetylpyridinium chloride 1 MG/ML Mucous Membrane Topical Solution — RxCUI 1251772

RxNorm drug concept · Semantic clinical drug
RxCUI 1251772 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251772
Official nameCetylpyridinium chloride 1 MG/ML Mucous Membrane Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascetylpyridinium chloride 0.1 % Mucous Membrane Topical Solution
FDA products mapped3
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Cetylpyridinium chloride 1 MG/ML Mucous Membrane... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cetylpyridinium chloride 1 MG/ML Mucous Membrane Topical Solution RxCUI 1251772

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cetylpyridinium 2286
    • Cetylpyridinium chloride 2287
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cetylpyridinium Mucous Membrane Topical Solution 582856
    • Cetylpyridinium chloride Mucous Membrane Topical Solution 2645918
    • Cetylpyridinium Mucosal Product 1152732
    • Cetylpyridinium chloride Mucosal Product 2661621
    • Mucous Membrane Topical Solution 316956
    • Mucosal Product 1151129
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cetylpyridinium chloride 1 MG/ML 452623

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cetylpyridinium chloride 1 MG/ML SCDC · 452623
  • Cetylpyridinium Mucous Membrane Topical Solution SCDF · 582856
  • Cetylpyridinium chloride Mucous Membrane Topical Solution SCDFP · 2645918
  • Cetylpyridinium Mucosal Product SCDG · 1152732
  • Cetylpyridinium chloride Mucosal Product SCDGP · 2661621

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 1251772 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10237-0261-01 1000 mL in 1 BOTTLE, PLASTIC (10237-261-01) Therabreath Deep Clean Fresh Mint Church & Dwight Co., Inc. 2026-01-01
10237-0261-03 88.7 mL in 1 BOTTLE, PLASTIC (10237-261-03) Therabreath Deep Clean Fresh Mint Church & Dwight Co., Inc. 2024-02-15
10237-0261-16 473 mL in 1 BOTTLE, PLASTIC (10237-261-16) Therabreath Deep Clean Fresh Mint Church & Dwight Co., Inc. 2024-02-15
10237-0261-26 2 BOTTLE, PLASTIC in 1 PACKAGE (10237-261-26) / 473 mL in 1... Therabreath Deep Clean Fresh Mint Church & Dwight Co., Inc. 2023-06-30
10237-0269-01 1 KIT in 1 CARTON (10237-269-01) * 473 mL in 1 BOTTLE, PLA... TheraBreath Church & Dwight Co., Inc. 2026-01-01
82442-0807-16 473 mL in 1 BOTTLE (82442-807-16) Up and Up Antiseptic Target Corporation 2025-09-01
Observed labelers: Church & Dwight Co., Inc. (5) · Target Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.